Anika Therapeutics (NASDAQ:ANIK – Get Free Report) is expected to post its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Anika Therapeutics to post earnings of ($0.01) per share and revenue of $29.00 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Anika Therapeutics Stock Performance
ANIK stock opened at $16.86 on Wednesday. The company has a market capitalization of $246.93 million, a P/E ratio of -2.54 and a beta of 0.89. The company has a fifty day moving average price of $16.87 and a 200-day moving average price of $19.98. Anika Therapeutics has a 52-week low of $15.40 and a 52-week high of $29.11.
Anika Therapeutics Company Profile
Read More
- Five stocks we like better than Anika Therapeutics
- Why Are These Companies Considered Blue Chips?
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Breakout Stocks: What They Are and How to Identify Them
- Tesla Stock: Finding a Bottom May Take Time
- Pros And Cons Of Monthly Dividend Stocks
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Anika Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.